Patient Safety and Healthcare Quality

 View Only
Back to discussions
Expand all | Collapse all

Advocate Excellence - COVID-19: ACC Advises Caution on Use of Troponin, Natriuretic Peptide Tests

  • 1.  Advocate Excellence - COVID-19: ACC Advises Caution on Use of Troponin, Natriuretic Peptide Tests

    Posted 03-25-2020 10:04
    Organization (Website) Origin: Medscape Medical News (http://www.medscape.com)

    Topic Brief:
    Two widely assayed cardiac biomarkers are often elevated in patients with coronavirus infection (COVID-19), for reasons that are still poorly understood, but tests for them shouldn't be ordered except for standard clinical reasons.

    That means assays for troponins and natriuretic peptides should be obtained only for such patients who have clinical signs of acute myocardial infarction (MI) or heart failure, respectively.

    Those are top-line messages from a short review posted by the American College of Cardiology (ACC) aimed in part at discouraging unnecessary application of widely-used heart-disease biomarker assays in the unfamiliar times of a global public health emergency.
    ((access the complete article below))

    URL:   https://www.medscape.com/viewarticle/927205?nlid=134607_1025&src=WNL_mdplsfeat_200324_mscpedit_path&uac=29841HJ&spon=43&impID=2323213&faf=1

    ------------------------------
    Lezlee Koch, ASCLS Patient Safety Committee
    ------------------------------


Related Content